Pharmacognosy Research

SHORT COMMUNICATION
Year
: 2015  |  Volume : 7  |  Issue : 4  |  Page : 397--400

Ammi Visnaga in treatment of urolithiasis and hypertriglyceridemia


Akshaya Srikanth Bhagavathula1, Ahed Jumah Mahmoud Al-Khatib2, Asim Ahmed Elnour3, Naama MS AlKalbani4, Abdulla Shehab5 
1 Department of Clinical Pharmacy, University of Gondar College of Medicine and Health Sciences, Gondar, Ethiopia
2 Department of Neurosciences, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
3 Department of Pharmacology, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates
4 Department of Pharmacy, Tawam Hospital, Abu Dhabi, United Arab Emirates
5 Department of Internal Medicine, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates

Correspondence Address:
Abdulla Shehab
Department of Internal Medicine, College of Medicine and Health Sciences, UAE University, Al Ain
United Arab Emirates

Ammi visnaga is a widely distributed Ancient Egyptian medicinal plant used for treatment of several diseases including urolithiasis (kidney stones). The active chemical constituents«SQ» khellin and visnagin obtained from the A. visnaga seeds have activity of antilithiogenic and pleiotropic. However, little is known about its activity on hypertriglyceridemia. The main aim of this review is to explore the use of A. visnaga in urolithiasis and to present a case of relevancy. We highlighted a case of a patient who has recurrent urethral stones and hypertriglyceridemia. The patient was treated with A. visnaga seeds, has recovered completely from ureteral stones and his high-density lipoprotein (HDL)-cholesterol low levels retained to normal after using of A. visnaga seeds for 10 days. The present case of A. visnaga seeds being local medicinal plant has shown the effect in treating urolithiasis with extended effect on raising HDL-cholesterol. These results may provide insights for in vitro studies for isolation of these biologically active compounds for potential in raising HDL-cholesterol. Whether or not the later effect can have clinical utility remains to be explored.


How to cite this article:
Bhagavathula AS, Mahmoud Al-Khatib AJ, Elnour AA, AlKalbani NM, Shehab A. Ammi Visnaga in treatment of urolithiasis and hypertriglyceridemia.Phcog Res 2015;7:397-400


How to cite this URL:
Bhagavathula AS, Mahmoud Al-Khatib AJ, Elnour AA, AlKalbani NM, Shehab A. Ammi Visnaga in treatment of urolithiasis and hypertriglyceridemia. Phcog Res [serial online] 2015 [cited 2020 Apr 4 ];7:397-400
Available from: http://www.phcogres.com/article.asp?issn=0974-8490;year=2015;volume=7;issue=4;spage=397;epage=400;aulast=Bhagavathula;type=0